skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: assunto: Gastroenterology And Hepatology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prophylaxis and treatment of hepatitis B in immunocompromised patients
Prophylaxis and treatment of hepatitis B in immunocompromised patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prophylaxis and treatment of hepatitis B in immunocompromised patients

Marzano, A ; Angelucci, E ; Andreone, P ; Brunetto, M ; Bruno, R ; Burra, P ; Caraceni, P ; Daniele, B ; Di Marco, V ; Fabrizi, F ; Fagiuoli, S ; Grossi, P ; Lampertico, P ; Meliconi, R ; Mangia, A ; Puoti, M ; Raimondo, G ; Smedile, A

Digestive and liver disease, 2007-05, Vol.39 (5), p.397-408 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Papatheodoridis, George V ; Dalekos, George N ; Yurdaydin, Cihan ; Buti, Maria ; Goulis, John ; Arends, Pauline ; Sypsa, Vana ; Manolakopoulos, Spilios ; Mangia, Giampaolo ; Gatselis, Nikolaos ; Keskın, Onur ; Savvidou, Savvoula ; Hansen, Bettina E ; Papaioannou, Christos ; Galanis, Kostantinos ; Idilman, Ramazan ; Colombo, Massimo ; Esteban, Rafael ; Janssen, Harry L.A ; Lampertico, Pietro

Journal of hepatology, 2015-02, Vol.62 (2), p.363-370 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
3
Chronic viral hepatitis: The histology report
Chronic viral hepatitis: The histology report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chronic viral hepatitis: The histology report

Guido, Maria ; Mangia, Alessandra ; Faa, Gavino

Digestive and liver disease, 2011-03, Vol.43, p.S331-S343 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Mortality rate and predictors of liver disease damage in histologically diagnosed Nonalcholic Steatohepatitis: a 15 years follow-up cohort study
Mortality rate and predictors of liver disease damage in histologically diagnosed Nonalcholic Steatohepatitis: a 15 years follow-up cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mortality rate and predictors of liver disease damage in histologically diagnosed Nonalcholic Steatohepatitis: a 15 years follow-up cohort study

Mangia, A ; Santoro, R ; Piazzolla, V ; Squillante, M.M ; Petruzzellis, D ; Agostinacchio, E ; Guido, M

Journal of hepatology, 2017, Vol.66 (1), p.S148-S148 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Prevalence and Clinical Importance of Hepatitis C Virus Genotype 2 K/1B Chimeras
Prevalence and Clinical Importance of Hepatitis C Virus Genotype 2 K/1B Chimeras
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence and Clinical Importance of Hepatitis C Virus Genotype 2 K/1B Chimeras

Susser, S ; Dietz, J ; Barak, M ; Schlevogt, B ; Daniel, R ; Piazzolla, V ; Passmann, S ; Cornberg, M ; Zuckerman, E ; Mangia, A ; Zeuzem, S ; Sarrazin, C

Journal of hepatology, 2016, Vol.64 (2), p.S136-S136 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER
P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER

Palescandolo, E ; Vijgen, L ; Talloen, W ; Colombo, M ; Mangia, A ; Wedemeyer, H ; Demasi, R ; Lonjon-Domanec, I ; Aerssens, J

Journal of hepatology, 2014-04, Vol.60 (1), p.S490-S491 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
7
IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients
IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients

Galmozzi, E ; Lampertico, P ; Facchetti, F ; Invernizzi, F ; Mangia, G ; Vigano, M ; Soffredini, R ; Colombo, M

Digestive and liver disease, 2015-02, Vol.47, p.e49-e49 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
815 FACTORS ASSOCIATED WITH INTOLERANCE TO PEGINTERFERON alfa/RIBAVIRIN IN TREATMENT-NAÏVE, CIRRHOTIC/NON-CIRRHOTIC HCV GENOTYPE 1-INFECTED PATIENTS: ANALYSIS OF DATA FROM THE MULTINATIONAL PROPHESYS COHORTS
815 FACTORS ASSOCIATED WITH INTOLERANCE TO PEGINTERFERON alfa/RIBAVIRIN IN TREATMENT-NAÏVE, CIRRHOTIC/NON-CIRRHOTIC HCV GENOTYPE 1-INFECTED PATIENTS: ANALYSIS OF DATA FROM THE MULTINATIONAL PROPHESYS COHORTS
Material Type:
Artigo 		Adicionar ao Meu Espaço

815 FACTORS ASSOCIATED WITH INTOLERANCE TO PEGINTERFERON alfa/RIBAVIRIN IN TREATMENT-NAÏVE, CIRRHOTIC/NON-CIRRHOTIC HCV GENOTYPE 1-INFECTED PATIENTS: ANALYSIS OF DATA FROM THE MULTINATIONAL PROPHESYS COHORTS

Firpi, R ; Reau, N ; Korner, E ; Hoop, R ; Han, J ; Mangia, A ; Ferenci, P ; Everson, G

Journal of hepatology, 2013-04, Vol.58, p.S334-S334 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
9
P1220 MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS
P1220 MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1220 MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS

Muir, A ; Nelson, D.R ; Gordon, S.C ; Feld, J.J ; Patel, K ; Lawitz, E ; Sheikh, A.M ; Brainard, D.M ; Symonds, W.T ; McHutchison, J.G ; Bekele, B.N ; Mangia, A ; Gane, E.J

Journal of hepatology, 2014-04, Vol.60 (1), p.S495-S495 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
10
5 PHASE 3 RANDOMIZED CONTROLLED TRIAL OF ALL-ORAL TREATMENT WITH SOFOSBUVIR + RIBAVIRIN FOR 12 WEEKS COMPARED TO 24 WEEKS OF PEG + RIBAVIRIN IN TREATMENT-NAÏVE GT2/3 HCV-INFECTED PATIENTS (FISSION)
5 PHASE 3 RANDOMIZED CONTROLLED TRIAL OF ALL-ORAL TREATMENT WITH SOFOSBUVIR + RIBAVIRIN FOR 12 WEEKS COMPARED TO 24 WEEKS OF PEG + RIBAVIRIN IN TREATMENT-NAÏVE GT2/3 HCV-INFECTED PATIENTS (FISSION)
Material Type:
Artigo 		Adicionar ao Meu Espaço

5 PHASE 3 RANDOMIZED CONTROLLED TRIAL OF ALL-ORAL TREATMENT WITH SOFOSBUVIR + RIBAVIRIN FOR 12 WEEKS COMPARED TO 24 WEEKS OF PEG + RIBAVIRIN IN TREATMENT-NAÏVE GT2/3 HCV-INFECTED PATIENTS (FISSION)

Gane, E ; Lawitz, E ; Rodriguez-Torres, M ; Gordon, S ; Dvory-Sobol, H ; Arterburn, S ; McNally, J ; Brainard, D.M ; Symonds, W.T ; McHutchison, J.G ; Sheikh, A ; Mangia, A

Journal of hepatology, 2013-04, Vol.58, p.S3-S3 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.